Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines

Author： Sonnemann Jürgen   Gänge Jennifer   Kumar K.   Müller Cornelia   Bader Peter   Beck James  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.2, 2005-01, pp. : 99-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 9, 2011-11 ,pp. : 861-867

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3673-3681

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 11, Iss. 7, 2005-03 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite

Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2548-2553

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of TNF-related apoptosis-inducing ligand receptor antibodies

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1081-1086

Informa Healthcare

Access to resources Recommend Favorite